Key Financial Data Of Reporting Company

AFC-HD AMS Life Science Co.,Ltd. - Filing #7267231

Concept As at
2025-02-28
2024-09-01 to
2025-02-28
As at
2024-08-31
2023-09-01 to
2024-08-31
As at
2024-02-29
2023-09-01 to
2024-02-29
Key financial data of reporting company
Business results of reporting company
Net sales
16,614,355,000 JPY
30,185,451,000 JPY
14,542,980,000 JPY
Ordinary profit (loss)
1,332,499,000 JPY
1,921,421,000 JPY
1,060,539,000 JPY
Net assets
14,773,029,000 JPY
13,958,098,000 JPY
13,631,707,000 JPY
Total assets
47,745,422,000 JPY
47,030,684,000 JPY
44,311,395,000 JPY
Basic earnings (loss) per share
62.65
89.20
45.79
Diluted earnings per share
62.64
89.11
45.74
Equity-to-asset ratio
0.307 xbrli:pure
0.296 xbrli:pure
0.307 xbrli:pure
Net cash provided by (used in) operating activities
565,886,000 JPY
1,540,093,000 JPY
-264,847,000 JPY
Net cash provided by (used in) investing activities
-1,940,512,000 JPY
-2,761,467,000 JPY
-1,354,435,000 JPY
Net cash provided by (used in) financing activities
594,347,000 JPY
2,232,074,000 JPY
707,537,000 JPY
Cash and cash equivalents
11,242,319,000 JPY
12,070,550,000 JPY
10,154,370,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.